Skip to main content
Clinical Trials/ITMCTR2100004254
ITMCTR2100004254RecruitingPhase 1

A randomized controlled study of the effect of percutaneous acupoint electrical stimulation on the incidence of postoperative nausea and vomiting in patients undergoing thoracic surgery

Shanghai General hospital0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
40 to 64 (—)
Sex
Female

Inclusion Criteria

  • 1) Patients undergoing thoracic surgery under elective general anesthesia;
  • 2) At least 18 years old and below 65 years old;
  • 3) BMI15-40kg/m2;
  • 4) ASA I - III level;
  • 5) PONV risk prediction score APFEL >= 3 points;
  • 6) Can understand and sign the informed consent, and cooperate with the completion of intervention and assessment.

Exclusion Criteria

  • 1) Pregnancy and lactation;
  • 2) The contraindication of transcutaneous electrical stimulation: the patients with skin allergy, damage, infection, itching, allergy to tape and pacemaker implantation at the test acupoint;
  • 3) A history of alcohol, opioid, or other substance abuse is confirmed/suspected;
  • 4) A history of neurological diseases (cerebral infarction, TIA, Parkinson's disease, mental retardation, craniocerebral injury);
  • 5) Participate in other clinical studies within 3 months before inclusion in this study.

Investigators

Similar Trials